Related Experiment Video
Updated: Mar 9, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Redo Mitral Valve Replacement for Prosthetic Valve Thrombosis: Single Center Experience
Jignesh Kothari1, Kartik Patel2, Bhavin Brahmbhatt3
1Professor, Department of Cardiothoracic and Vascular Surgery, U. N. Mehta, Institute of Cardiology and Research Center , New Civil Hospital Campus, Asarwa, Ahmedabad, Gujarat, India .
Prosthetic Valve Thrombosis (PVT) is a serious complication after valve replacement. Redo mitral valve surgery for PVT carries a high mortality risk, especially in unstable patients.
Area of Science:
- Cardiovascular Surgery
- Cardiac Valve Disease
- Thrombosis Research
Background:
- Prosthetic Valve Thrombosis (PVT) significantly increases morbidity and mortality post-valve replacement.
- While surgery is often life-saving for obstructive PVT, optimal treatment strategies require further investigation.
Purpose of the Study:
- To identify risk factors and outcomes for patients undergoing redo mitral valve surgery due to acute PVT.
- To analyze pre-operative, intra-operative, and post-operative factors influencing patient outcomes.
Main Methods:
- A retrospective study of 65 patients who underwent redo mitral valve surgery for obstructive PVT between January 2012 and February 2015.
- Exclusion criteria included acute PVT of the aortic valve or combined valves.
- Data collected included pre-operative, intra-operative, and post-operative factors, along with follow-up data.
Main Results:
- The overall mortality rate was 29.2% (19/65).
- Mortality was significantly higher in patients undergoing direct surgery (46%) compared to those with failed thrombolysis (10%).
- Higher mortality was observed in patients with New York Heart Association (NYHA) III/IV class compared to NYHA I/II class (p=0.02).
Conclusions:
- PVT remains a challenging post-operative complication with high mortality, irrespective of treatment.
- Surgical management of PVT, though life-saving, poses significant risks, particularly for hemodynamically unstable patients or those in NYHA class III/IV.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Mitral Regurgitation I: Introduction
Mitral Stenosis I: Introduction
Mitral Valve Prolapse I: Introduction
Mitral Valve Prolapse II: Assessment and Management

